Corey E - Search Results

1

Multiplexed functional genomic analysis of 5' untranslated region mutations across the spectrum of prostate cancer.

Lim Y, Arora S, Schuster SL, Corey L, Fitzgibbon M, Wladyka CL, Wu X, Coleman IM, Delrow JJ, Corey E, True LD, Nelson PS, Ha G, Hsieh AC. Lim Y, et al. Among authors: corey e, corey l. Nat Commun. 2021 Jul 9;12(1):4217. doi: 10.1038/s41467-021-24445-6. Nat Commun. 2021. PMID: 34244513 Free PMC article.

2

Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer.

Liu AY, Corey E, Vessella RL, Lange PH, True LD, Huang GM, Nelson PS, Hood L. Liu AY, et al. Among authors: corey e. Prostate. 1997 Feb 15;30(3):145-53. doi: 10.1002/(sici)1097-0045(19970215)30:3<145::aid-pros1>3.0.co;2-l. Prostate. 1997. PMID: 9122038

3

Osteoprotegerin and rank ligand expression in prostate cancer.

Brown JM, Corey E, Lee ZD, True LD, Yun TJ, Tondravi M, Vessella RL. Brown JM, et al. Among authors: corey e. Urology. 2001 Apr;57(4):611-6. doi: 10.1016/s0090-4295(00)01122-5. Urology. 2001. PMID: 11306358

4

Cathepsin K mRNA and protein expression in prostate cancer progression.

Brubaker KD, Vessella RL, True LD, Thomas R, Corey E. Brubaker KD, et al. Among authors: corey e. J Bone Miner Res. 2003 Feb;18(2):222-30. doi: 10.1359/jbmr.2003.18.2.222. J Bone Miner Res. 2003. PMID: 12568399 Free article.

5

Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia.

Wang Z, Corey E, Hass GM, Higano CS, True LD, Wallace D Jr, Tisdale MJ, Vessella RL. Wang Z, et al. Among authors: corey e. Int J Cancer. 2003 May 20;105(1):123-9. doi: 10.1002/ijc.11035. Int J Cancer. 2003. PMID: 12672042

6

LuCaP 35: a new model of prostate cancer progression to androgen independence.

Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, Vessella RL. Corey E, et al. Prostate. 2003 Jun 1;55(4):239-46. doi: 10.1002/pros.10198. Prostate. 2003. PMID: 12712403

7

Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastases.

Roudier MP, Corey E, True LD, Hiagno CS, Ott SM, Vessell RL. Roudier MP, et al. Among authors: corey e. Cancer Treat Res. 2004;118:311-39. doi: 10.1007/978-1-4419-9129-4_13. Cancer Treat Res. 2004. PMID: 15043198 Review. No abstract available.

8

Metastases of prostate cancer express estrogen receptor-beta.

Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL, Corey E. Lai JS, et al. Among authors: corey e. Urology. 2004 Oct;64(4):814-20. doi: 10.1016/j.urology.2004.05.036. Urology. 2004. PMID: 15491740

9

Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.

Coleman IM, Kiefer JA, Brown LG, Pitts TE, Nelson PS, Brubaker KD, Vessella RL, Corey E. Coleman IM, et al. Among authors: corey e. Neoplasia. 2006 Oct;8(10):862-78. doi: 10.1593/neo.06328. Neoplasia. 2006. PMID: 17032503 Free PMC article.

10

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.

Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, Nelson PS, Coleman R, Wang YC, Corey E, Lange PH, Higano CS, Vessella RL. Morrissey C, et al. Among authors: corey e. Clin Exp Metastasis. 2008;25(4):377-88. doi: 10.1007/s10585-007-9116-4. Epub 2007 Oct 31. Clin Exp Metastasis. 2008. PMID: 17972146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters